cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 Results
Rhea-AI Summary
cbdMD, Inc. (NYSE American: YCBD), a leading CBD company, has announced it will host a conference call to discuss its second quarter fiscal year 2025 financial results for the period ending March 31, 2025. The conference call is scheduled for Thursday, May 15, 2025, at 4:20 p.m. Eastern Time. Participants can join via USA/Canada (833-821-3524) or International (647-846-2919) dial-in numbers. A replay will be available through dedicated phone lines and a webcast replay link will remain accessible until May 15, 2026.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, YCBD gained 8.72%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Charlotte, North Carolina--(Newsfile Corp. - May 9, 2025) - cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, May 15, 2025, to discuss the company's March 31, 2025 second quarter of fiscal year 2025 financial results and business progress.
CONFERENCE CALL DETAILS
| Thursday, May 15, 2025, 4:20 p.m. Eastern Time | ||
| USA/Canada: | 833-821-3524 | |
| International: | 647-846-2919 | |
| Teleconference Replay dial in: | ||
| USA/Canada: | 855-669-9658 | |
| International: | 412-317-0088 | |
| Replay Passcode: | 7254091 | |
| Webcast/Webcast Replay link - available through May 15, 2026: | ||
https://www.gowebcasting.com/14065
About cbdMD, Inc.
cbdMD, Inc. (NYSE American: YCBD) is one of the leading and most highly trusted and most recognized cannabidiol (CBD) brands with a comprehensive line of U.S. produced THC-free1 CBD products and an array of Farm Act compliant Delta 9 products. Our Paw CBD brand of pet products includes veterinarian-formulated products and our ATRx brand features functional mushroom products. In addition, we operate Herbal Oasis, a premium, award winning THC-infused social seltzer that blends cannabinoids and nootropic mushrooms to deliver a fast-acting, functional beverage made for presence and connection. With an alcohol-free formula and wellness-forward ingredients, Oasis invites a better way to drink-one rooted in clarity, balance, and joy. To learn more about cbdMD and our comprehensive line of U.S. grown, THC-free1 CBD and Full Spectrum products as well as our other brands, please visit www.cbdmd.com, www.pawcbd.com, ATRxlabs.com, or Herbaloasis.com, follow cbdMD on Instagram and Facebook, or visit one of the thousands of retail outlets that carry cbdMD's products.
(1) THC-free is defined as below the level of detection using validated scientific analytical methods.
Contact Information:
cbdMD, Inc.
Ronan Kennedy, CEO and CFO
Phone: +1 (704) 445-3064
email: IR@cbdmd.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/251499
FAQ
When is cbdMD (YCBD) reporting Q2 2025 earnings?
How can I join the cbdMD (YCBD) Q2 2025 earnings call?
How long will the cbdMD (YCBD) Q2 2025 earnings call replay be available?
What period will cbdMD's (YCBD) Q2 2025 earnings report cover?
